Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

MetLife (MET) Q2 EPS Falls 11%


(NYSE:MET), a leading global insurance and financial services provider, reported its latest quarterly results on August 6, 2025. The company’s latest earnings release revealed that non-GAAP earnings and revenue trailed Wall Street expectations, with both adjusted (non-GAAP) earnings per share and total revenue missed analyst forecasts. Actual adjusted earnings per share (Non-GAAP) came in at $2.02, versus the anticipated $2.15 (non-GAAP), while GAAP revenue reached $17.34 billion, falling short of the $18.53 billion non-GAAP consensus. Net income (GAAP) dropped to $698 million, down from $912 million in net income (GAAP) for Q2 2024. Despite pressures on profitability, Book value per share increased 7% to $35.79 and adjusted book value per share increased 6% to $56.23. The quarter was marked by weaker-than-expected underwriting, lower investment margins, and Variable investment income decreased. Overall, the company posted a mixed quarter with strength in capital management and international sales, but softness in core profitability.

Source: Analyst estimates for the quarter provided by FactSet.

MetLife is one of the world’s largest insurance and financial services companies. It operates across several segments, including group benefits, retirement solutions, asset management, and international life and health protection products. Its business model revolves around recurring revenue from insurance premiums, investment income, and asset management fees, with a global scale spanning the United States, Asia, Latin America, and the EMEA (Europe, Middle East, Africa) region.

Continue reading


Source Fool.com

Metlife Inc. Stock

€68.71
-2.920%
We can see a decrease in the price for Metlife Inc.. Compared to yesterday it has lost -€2.070 (-2.920%).
With 35 Buy predictions and not a single Sell prediction Metlife Inc. is an absolute favorite of our community.
As a result the target price of 85 € shows a positive potential of 23.71% compared to the current price of 68.71 € for Metlife Inc..
Like: 0
MET
Share

Comments